Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats (Q41749031)

8 October 2017

title

Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A470544

4 July 2022

author name string

S. J. List

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A470544

4 July 2022

P. Seeman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A470544

4 July 2022

language of work or name

English

0 references

publication date

1 April 1979

1 reference

8 October 2017

16 April 1979

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=470544

full work available at URL

4 July 2022

https://api.elsevier.com/content/article/PII:0024320579900274?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

https://api.elsevier.com/content/article/PII:0024320579900274?httpAccept=text/plain

30 May 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

30 May 2023

1 reference

8 October 2017

volume

24

1 reference

8 October 2017

issue

16

1 reference

8 October 2017

page(s)

1447-1452

1 reference

8 October 2017

cites work

Persistent Dyskinesia

2

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

Tardive Dyskinesia: An Evaluation of the Etiologic Association with Neuroleptic Therapy

30 May 2023

3

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

The pharmacology of tardive dyskinesias

30 May 2023

4

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

30 May 2023

5

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine

30 May 2023

7

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

Dopaminergic supersensitivity in striatum and olfactory tubercle following chronic administration of haloperidol or clozapine

30 May 2023

8

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

30 May 2023

11

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors

30 May 2023

12

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

Increased in vivo binding of 3H-Pimozide in mouse striatum following repeated administration of haloperidol

30 May 2023

14

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains

30 May 2023

15

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

L-DOPA reversal of hyperdopaminergic behaviour

30 May 2023

18

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

Anti-schizophrenic drugs—Membrane receptor sites of action

30 May 2023

19

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

Direct evidence for presynaptic and postsynaptic dopamine receptors in brain

30 May 2023

20

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

Differential centrifugation of 3H-apomorphine and 3H-spiroperidol binding sites

30 May 2023

22

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

Receptor basis for dopaminergic supersensitivity in Parkinson's disease

30 May 2023

23

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

Protein measurement with the Folin phenol reagent

30 May 2023

26

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding

30 May 2023

27

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

Chemical lesion and drug induced supersensitivity and subsensitivity of caudate dopamine receptors

30 May 2023

30

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

Subsensitivity of the rat striatal dopaminergic system after treatment with bromocriptine: effects on [3H]spiperone binding and dopamine-stimulated cyclic AMP formation

30 May 2023

31

1 reference

https://api.crossref.org/works/10.1016/0024-3205(79)90027-4

30 May 2023

Identifiers

1 reference

8 October 2017

1 reference